Hypertension and dyslipidemia: the two partners in endothelium-related crime
E Dąbrowska, K Narkiewicz - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review The goal of this article is to characterize the endothelium's role
in the development of hypertension and dyslipidemia and to point out promising therapeutic …
in the development of hypertension and dyslipidemia and to point out promising therapeutic …
Omics approaches unveiling the biology of human atherosclerotic plaques
Atherosclerosis is a chronic inflammatory disease of the arterial wall, characterized by the
buildup of plaques with the accumulation and transformation of lipids, immune cells …
buildup of plaques with the accumulation and transformation of lipids, immune cells …
Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition
Current cardiometabolic disease prevention guidelines recommend increasing dietary
unsaturated fat intake while reducing saturated fats. Here we use lipidomics data from a …
unsaturated fat intake while reducing saturated fats. Here we use lipidomics data from a …
Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challenges
T Abrahams, SJ Nicholls - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Plasma lipidomics has emerged as a powerful tool in cardiovascular drug
discovery by providing insights into disease mechanisms, identifying potential biomarkers …
discovery by providing insights into disease mechanisms, identifying potential biomarkers …
Percentiles of predicted 10-year cardiovascular disease risk by sex and age in Brazil and their association with estimated risk of long-term atherosclerotic events
Objective Expressing the cardiovascular disease (CVD) risk in relation to peers may
complement the estimation of absolute CVD risk. We aimed to determine 10-year CVD risk …
complement the estimation of absolute CVD risk. We aimed to determine 10-year CVD risk …
Plasma lipidomics profiles highlight the associations of the dual antioxidant/pro-oxidant molecules sphingomyelin and phosphatidylcholine with subclinical …
L Sojo, E Santos-González, L Riera, A Aguilera… - Antioxidants, 2023 - mdpi.com
Here, we report on our study of plasma lipidomics profiles of patients with type 1 diabetes
(T1DM) and explore potential associations. One hundred and seven patients with T1DM …
(T1DM) and explore potential associations. One hundred and seven patients with T1DM …
[HTML][HTML] Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention
P Royer, E Björnson, M Adiels, MB Álvez… - American Heart …, 2024 - Elsevier
Background and aims Recent developments in high-throughput proteomic technologies
enable the discovery of novel biomarkers of coronary atherosclerosis. The aims of this study …
enable the discovery of novel biomarkers of coronary atherosclerosis. The aims of this study …
Lipidomic-Based Algorithms Can Enhance Prediction of Obstructive Coronary Artery Disease
T Mouskeftara, O Deda, T Liapikos… - Journal of Proteome …, 2024 - ACS Publications
Lipidomics emerges as a promising research field with the potential to help in personalized
risk stratification and improve our understanding on the functional role of individual lipid …
risk stratification and improve our understanding on the functional role of individual lipid …
Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
W Deng, D Wang, Y Wan, S Lai, Y Ding… - Frontiers in …, 2024 - frontiersin.org
Background The number of models developed for predicting major adverse cardiovascular
events (MACE) in patients undergoing percutaneous coronary intervention (PCI) is …
events (MACE) in patients undergoing percutaneous coronary intervention (PCI) is …
Pro-Inflammatory Biomarkers and Progression of Atherosclerosis in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery Disease: 1-Year Follow …
VV Ryabov, DA Vorobeva, IV Kologrivova… - Journal of Personalized …, 2023 - mdpi.com
The objective of our study was to evaluate the concentrations of pro-inflammatory
biomarkers in patients with acute myocardial infarction with non-obstructive coronary …
biomarkers in patients with acute myocardial infarction with non-obstructive coronary …